ReviewGlobal health & medicine2021

Current status of immune checkpoint inhibitor therapy for advanced esophageal squamous cell carcinoma.

Naoki Enomoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.